news

 

Indian law firm Trilegal has guided infrastructure investment trust Highways Infrastructure Trust (HIT) on its approximately $1.08 billion acquisition of 12 road projects from PNC Infratech, which was advised by Shardul Amarchand Mangaldas.

 

The deal is one of India’s largest-ever transactions in the roads sector. It comprises 11 hybrid annuity concessions from the national highways regulator, the National Highways Authority of India, and one toll road concession from state regulator, Uttar Pradesh State Highways Authority.

HIT in an InvIT linked to funds managed by international investment giant KKR.

The team at Trilegal was led by projects partners Neeraj Menon and Amar Narula and corporate partner Sneha Vardhan. Partner Apeksha Mattoo advised on the labour and employment aspects of the deal, and partners Nisha Uberoi and Rudresh Singh advised on competition law aspects.

The SAM team that advised PNC Infratech on the deal was led by partners Kushal Sinha and Dhrupad Pant.

 

TO CONTACT EDITORIAL TEAM, PLEASE EMAIL ALBEDITOR@THOMSONREUTERS.COM

Related Articles

TT&A, Luthra advise on $244 mln Zomato acquisition of Paytm’s ticketing business

by Nimitt Dixit |

Talwar Thakore & Associates has advised India’s Zomato on its 20 million rupees ($244.2 million) acquisition of the movie and events ticketing businesses of digital payments firm Paytm, owned by One97 Communications, which was represented by Luthra and Luthra Law Offices.

CAM, Tatva Legal Hyderabad guide $1.2 bln Ambuja Cement acquisition

by Nimitt Dixit |

Cyril Amarchand Mangaldas has advised Gautam Adani’s Ambuja Cement on its acquisition of Penna Cement Industries from its promoter group for 104 billion rupees ($1.24 billion). Penna and its promoters were advised by Tatva Legal, Hyderabad on the deal. 

SAM, AZB advise on $188 mln Netherlands-India life sciences deal

Shardul Amarchand Mangaldas & Co has advised Netherlands-headquartered speciality ingredient solutions provider Barentz International on its acquisition of India-based Anshul Life Sciences, which was represented by AZB & Partners.